Dr. Abdul Muqtadir Abbasi/LinkedIn
Dec 9, 2025, 13:25
Dr. Abdul Muqtadir Abbasi: The Effect of Recombinant Factor VIIa Treatment in Non-Traumatic Intracranial Hemorrhage
Dr. Abdul Muqtadir Abbasi, Assistant Consultant at King Faisal Specialist Hospital and Research Center, shared a post on LinkedIn:
“My Abstract in Blood.”
Title: The effect of recombinant factor VIIa treatment in non-traumatic intracranial hemorrhage: Systematic review and meta-analysis
Authors: Dalal Aldhafeeri, Mohammed Almakadi, Anila K N, Saraswathy S Nair, Sadin Alamri, Aseel Alamri, Manal Alzahrani, Nouf Eldabai, Hassan Alharbi, Gutaybah Alqarni, Abdul Muqtadir Abbasi, Zubair Mohamed, Mohammad Ebraheem
Read full study here.
Follow the latest in Hemostasis Today.
Abdul Muqtadir Abbasi
American Society of Hematology (ASH)
Anila K N
Aseel Alamri
ASH2025
ASH25
Blood
Dalal Aldhafeeri
factor VIIa
Gutaybah Alqarni
Hassan Alharbi
Health
Hematology
Hemostasis
Hemostasis Today
Intracranial Hemorrhage
Manal Alzahrani
Medicine
Mohammad Ebraheem
Mohammed Almakadi
Nouf Eldabai
Sadin Alamri
Saraswathy S Nair
Zubair Mohamed
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show